| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 5e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 0.0004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |